Clinical trials: Neck Cancer
Head and Neck Cancer
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy
The purpose of this study is to evaluate the efficacy, safety and tolerability of palifermin on the incidence of oral mucositis in subjects with locally advanced head and neck cancer receiving postoperative radiotherapy.
- Trial name
- NCT00540332
- Testing
- palifermin
- Sponsor
- Swedish Orphan Biovitrum
HPV16 Associated Cervical Cancer
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
This study will be looking at what dose of the TA-CIN vaccine is safe and effective in patients with a history of HPV16-associated cervical cancer.
- Trial name
- NCT02405221
- Testing
- TA-CIN (arm), TA-CIN (thigh)
- Where
- 2 sites in United States
- Volunteers
- 15 people
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Endometrial Cancer
Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer
Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer: a multicenter prospective randomized study
- Trial name
- SLN_EC (NCT04302714)
- Testing
- Hysteroscopic injection, Cervical injection
- Where
- Italy
- Volunteers
- 165 people
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Esophageal Cancer, Lung Cancer
Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung Carcinomas
Neo-adjuvant chemoradiotherapy (neo-CRT) is increasingly applied in the curative treatment of esophageal cancer, with the aim to downstage the tumor, to increase the rate of radical resections, and consequently to improve the…
- Trial name
- ABC (NCT02497664)
- Testing
- Active Breathing Control
- Where
- Netherlands
- Volunteers
- 22 people
- Sponsor
- University Medical Center Groningen
Barrett Esophagus, Esophageal Cancer
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
Esophageal cancer is a deadly disease that is becoming increasingly common in the United States. Barrett's esophagus (BE) is a pre-cancerous state that can develop into esophageal cancer, but is highly treatable.
- Trial name
- NCT05056051
- Testing
- WATS-3D tissue sampling prior to forceps biopsies, WATS-3D tissue sampling following forceps biopsies
- Where
- 4 sites in United States
- Volunteers
- 200 people
- Sponsor
- Northwestern University
Adenoid Cystic Carcinoma, Head and Neck Cancer
Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma
This is a Phase II, open-label, non-randomized, multicenter study to evaluate the clinical efficacy and safety of HG146 in participants with recurrent or metastatic adenoid cystic carcinoma. This study is divided into two stages.
- Trial name
- HG146 (NCT06781567)
- Testing
- HG146
- Where
- China
- Volunteers
- 140 people
- Sponsor
- HitGen Inc.
Head and Neck Cancers
Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma
The prognosis of patients with locally advanced SCCHN is poor. Results of recent randomized trials evaluating induction chemotherapy by docetaxel, cisplatin, 5 fluorouracil are conflicting, and benefit on overall survival is…
- Trial name
- MEDINDUCTION (NCT02997332)
- Testing
- Durvalumab, Docetaxel, Cisplatin
- Where
- France
- Volunteers
- 14 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells.
- Conditions
- Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer, Oral Complications, Radiation Toxicity
- Trial name
- NCT00025298
- Testing
- amifostine trihydrate, carboplatin, cisplatin
- Where
- 13 sites in Belgium, France and 4 more
- Volunteers
- 5 people
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
Nasopharyngeal Cancer
Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma
This study evaluates whether some patients with nasopharyngeal carcinoma but with low risk of distant metastasis can be treated with only radiotherapy and concomitant chemotherapy but without additional adjuvant chemotherapy.
- Trial name
- NCT03175939
- Testing
- Radiotherapy, Cisplatin, 5-FU
- Volunteers
- 263 people
- Sponsor
- Sun Yat-sen University
Lung Cancer, Head and Neck Cancer
Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy
In this study, the investigators obtain wearable disease based biomarkers from patients diagnosed with cancer and undergoing chemotherapy, and simultaneously measure patient self-reported adverse events through an app to evaluate…
- Conditions
- Lung Cancer, Head and Neck Cancer, Esophageal Cancer
- Trial name
- NCT05937477
- Testing
- Fitbit smartwatch
- Where
- South Korea
- Volunteers
- 500 people
- Sponsor
- Sehhoon Park
Esophageal Squamous Cell Carcinoma
PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy
As there is no consensus to date on the optimal postoperative nutritional support route for patients undergoing minimally invasive esophagectomy, the purpose of this study is to assess whether there is a potential advantage to…
- Trial name
- NCT06192212
- Where
- China
- Volunteers
- 577 people
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Esophageal Squamous Cell Carcinoma
Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC
Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for non-cCR patients after neoadjuvant chemoradiotherapy in locally advanced ESCC.
- Trial name
- ETNT (NCT05189730)
- Testing
- Tirelizumab, Paclitaxel, Carboplatin
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Sichuan Cancer Hospital and Research Institute
Thyroid Cancer
Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma
The purpose of this study is to assess whether therapy with Sorafenib reinduces radioiodine uptake in thyroid carcinoma.
- Trial name
- NCT00887107
- Testing
- Sorafenib (nexavar)
- Where
- Netherlands
- Volunteers
- 32 people
- Sponsor
- Leiden University Medical Center
Head and Neck Cancer, Head and Neck Carcinoma
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
The purpose of this study is to test the treatment approach of de-escalated radiation and chemotherapy followed by a planned neck dissection surgery in people with head and neck cancer.
- Conditions
- Head and Neck Cancer, Head and Neck Carcinoma, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma
- Trial name
- NCT05544136
- Testing
- 18F-FMISO PET/CT scan, Chemoradiation therapy, Carboplatin
- Where
- 6 sites in United States
- Volunteers
- 12 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Epithelial Tumor, Malignant, Neuroendocrine Tumors
Proton Boost for Locally Advanced HEAD AND NECK TUMORS
The aim of this research project is to test the local response and the acute toxicity (which can be observed within 90 days).
- Trial name
- NCT03183271
- Testing
- external beam proton radiation therapy.
- Where
- Italy
- Volunteers
- 20 people
- Sponsor
- CNAO National Center of Oncological Hadrontherapy
Thyroid Carcinoma, Thyroid Cancer
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
The purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors.
- Conditions
- Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular, Thyroid Cancer (Follicular Cell)
- Trial name
- NCT04462471
- Testing
- I-124 PET/CT lesion dosimetry, Vemurafenib, Copanlisib
- Where
- 7 sites in United States
- Volunteers
- 8 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Cervical Cancer
SUV Max as Predictor of Outcome in Cervical Cancer
Cervical Cancer is staged clinically, not surgically. Patients in whom an extensive disease is identified are not usually eligible for surgery. PET-CT is used to support staging.
- Trial name
- NCT01262144
- Testing
- Radiotherapy
- Where
- Israel
- Volunteers
- 50 people
- Sponsor
- Rambam Health Care Campus
Head and Neck Cancer
Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma
Chemo-radiotherapy (CRT) is currently the cornerstone in the management of locoregional advanced head and neck cancer (HNC). Optimization of the quality of RT is therefore an important issue, if the investigators want to improve…
- Trial name
- NCT01827709
- Testing
- A polymerase chain reaction -based hypoxia classifier, Functional imaging before treatment., Immunohistochemical staining
- Where
- Belgium
- Volunteers
- 11 people, healthy volunteers welcome
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Oral Cancer, Laryngeal Cancer
The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis
The purpose of this study is to investigate the role of lymphangiogenesis in the metastasis of head and neck cancer.
- Conditions
- Oral Cancer, Laryngeal Cancer, Hypopharyngeal Cancer
- Trial name
- NCT00173381
- Where
- Taiwan
- Volunteers
- 100 people
- Sponsor
- National Taiwan University Hospital
Oral Cancer
The Oral Microbiome in OSCC
Previous work by a number of scientific teams has revealed that the types of bacteria that colonize the mouth differ between health and pre-cancerous or cancerous oral lesions.
- Trial name
- NCT04925700
- Testing
- ProDentis Lozenge
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Iowa
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.